<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.drugs.v2.DrugResultsOutput xmlns:ns2="local" hits="10" offset="0" totalResults="24259"><SearchResults><Drug id="75799" name="autologous NY-ESO-1-targeting dendritic cell vaccine (cancer), Roswell Park Comprehensive Cancer Center" lastModificationDate="2018-06-11T00:00:00Z" phaseHighest="Phase 1 Clinical"><CompanyOriginator>Roswell Park Comprehensive Cancer Center</CompanyOriginator><CompaniesPrimary><Company>Roswell Park Comprehensive Cancer Center</Company></CompaniesPrimary><IndicationsPrimary><Indication>Fallopian tube cancer</Indication><Indication>Ovary tumor</Indication><Indication>Peritoneal tumor</Indication></IndicationsPrimary><ActionsPrimary><Action>Cancer testis antigen NY-ESO-1 modulator</Action></ActionsPrimary><Technologies><Technology>Biological therapeutic</Technology><Technology>Cell therapy</Technology><Technology>Subcutaneous formulation</Technology><Technology>Virus recombinant</Technology></Technologies><Summary>triad of costimulatory molecules (B7-1, ICAM-1 and LFA-3), for the potential sc treatment of &lt;b&gt;cancer&lt;/b&gt;, including ovarian, peritoneal and fallopian tube &lt;b&gt;cancer&lt;/b&gt; [ 2042231 ], [ 1267438 ], [...1257708 ], [ 1267440 ], [ 1267443 ], [ 2042231 ]. By February 2004, a clinical trial was underway in patients with ovarian &lt;b&gt;cancer&lt;/b&gt;. In June 2011, a phase I trial was completed [ 1267439 ]. By June 2014, another phase I trial was ongoing [ 1267438 ].</Summary><ActionsSecondary><Action>Anticancer</Action><Action>Dendritic cell vaccine</Action><Action>Genetically engineered autologous cell vaccine</Action><Action>Therapeutic vaccine</Action></ActionsSecondary><AddedDate>2012-01-27T00:00:00Z</AddedDate></Drug><Drug id="45057" name="NY-ESO-1 vaccine (protein), Ludwig Institute" lastModificationDate="2018-07-09T00:00:00Z" phaseHighest="Phase 2 Clinical"><CompanyOriginator>Ludwig Institute for Cancer Research</CompanyOriginator><CompaniesPrimary><Company>Ludwig Institute for Cancer Research</Company></CompaniesPrimary><IndicationsPrimary><Indication>Melanoma</Indication></IndicationsPrimary><ActionsPrimary><Action>Cancer testis antigen NY-ESO-1 modulator</Action></ActionsPrimary><Technologies><Technology>Biological therapeutic</Technology><Technology>Intramuscular formulation</Technology><Technology>Tumor antigen</Technology></Technologies><Summary>The Ludwig Institute for &lt;b&gt;Cancer&lt;/b&gt; Research (LICR) is developing a therapeutic vaccine based on the tumor antigen NY-ESO-1 using CSL 's ISCOM technology for the potential treatment for &lt;b&gt;cancer&lt;/b&gt;, primarily melanoma [ 455844 ]. In May 2014, a phase II data were presented [ 1560467 ]. In April 2013, a phase I trial was initiated in the US in patients with metastatic melanoma. At that time, the trial was expected to complete in May 2016. In October 2015, the trial was ongoing [ 1713389 ].</Summary><IndicationsSecondary><Indication>Cancer</Indication></IndicationsSecondary><ActionsSecondary><Action>Anticancer</Action><Action>Therapeutic vaccine</Action></ActionsSecondary><AddedDate>2003-05-21T00:00:00Z</AddedDate></Drug><Drug id="45079" name="NY-ESO-1 vaccine (peptides), Ludwig Institute/Peking University/Jewim Pharmaceutical" lastModificationDate="2019-05-30T00:00:00Z" phaseHighest="Phase 2 Clinical"><CompanyOriginator>Ludwig Institute for Cancer Research</CompanyOriginator><CompaniesPrimary><Company>Ludwig Institute for Cancer Research</Company></CompaniesPrimary><IndicationsPrimary><Indication>Melanoma</Indication></IndicationsPrimary><ActionsPrimary><Action>Cancer testis antigen NY-ESO-1 modulator</Action></ActionsPrimary><Technologies><Technology>Biological therapeutic</Technology><Technology>Peptide</Technology><Technology>Subcutaneous formulation</Technology><Technology>Tumor antigen therapeutic</Technology></Technologies><Summary>for &lt;b&gt;Cancer&lt;/b&gt; Research (LICR) is developing vaccines, based on peptides of the tumor antigen NY-ESO-1 that elicit a cytotoxic T-cell response, for the potential treatment of &lt;b&gt;cancer&lt;/b&gt; [ 490400 ]. In January 2015, a phase II trial for melanoma...Research, were developing NY-ESO-1b peptide vaccine in China, for the potential treatment of liver &lt;b&gt;cancer&lt;/b&gt;. In December 2008, the drug was in phase I trial [ 1468241 ], [ 1468242 ], [ 1468244 ], [ 1468247 ]. In October 2014, it was under development</Summary><CompaniesSecondary><Company>Jewim Pharmaceutical Inc</Company><Company>Peking University</Company></CompaniesSecondary><IndicationsSecondary><Indication>Cancer</Indication><Indication>Liver tumor</Indication></IndicationsSecondary><ActionsSecondary><Action>Anticancer</Action><Action>Protein subunit vaccine</Action><Action>Therapeutic vaccine</Action></ActionsSecondary><AddedDate>2003-05-22T00:00:00Z</AddedDate></Drug><Drug id="45059" name="NY-ESO-1 DNA vaccine (cancer), Ludwig Institute/PowderMed" lastModificationDate="2017-02-13T00:00:00Z" phaseHighest="Discontinued"><CompanyOriginator>Ludwig Institute for Cancer Research</CompanyOriginator><ActionsPrimary><Action>Cancer testis antigen NY-ESO-1 modulator</Action></ActionsPrimary><Technologies><Technology>Biological therapeutic</Technology><Technology>Transdermal formulation</Technology><Technology>Transdermal high velocity particle formulation</Technology></Technologies><Summary>the potential treatment of &lt;b&gt;cancer&lt;/b&gt; [ 539274 ], [ 762237 ]. In September 2004, phase I trials were initiated [ 559440 ]; these were ongoing in January 2007 [ 762237 ]. However, since that date no further development...time, PowderMed expected the vaccine to enter clinical trials for lung &lt;b&gt;cancer&lt;/b&gt; within 2 years [ 539274 ]. LICR is also developing an NY-ESO-1 protein vaccine with CSL ,and an NY-ESO-1 pox-virus &lt;b&gt;cancer&lt;/b&gt; vaccine with Therion .</Summary><CompaniesSecondary><Company>Ludwig Institute for Cancer Research</Company><Company>PowderJect Pharmaceuticals plc</Company><Company>PowderMed Ltd</Company></CompaniesSecondary><IndicationsSecondary><Indication>Cancer</Indication></IndicationsSecondary><ActionsSecondary><Action>Anticancer</Action><Action>DNA vaccine</Action><Action>Therapeutic vaccine</Action></ActionsSecondary><AddedDate>2003-05-21T00:00:00Z</AddedDate></Drug><Drug id="55922" name="SCIB-2" lastModificationDate="2019-05-30T00:00:00Z" phaseHighest="Discovery"><CompanyOriginator>Scancell Ltd</CompanyOriginator><CompaniesPrimary><Company>Cancer Research UK</Company><Company>Scancell Ltd</Company></CompaniesPrimary><IndicationsPrimary><Indication>Non-small-cell lung cancer</Indication><Indication>Solid tumor</Indication></IndicationsPrimary><ActionsPrimary><Action>Cancer testis antigen NY-ESO-1 modulator</Action></ActionsPrimary><Technologies><Technology>Biological therapeutic</Technology><Technology>Liposome formulation</Technology><Technology>Nanoparticle formulation</Technology><Technology>Parenteral formulation unspecified</Technology><Technology>Protein fusion</Technology></Technologies><Summary>lung &lt;b&gt;cancer&lt;/b&gt; (NSCLC), lung &lt;b&gt;cancer&lt;/b&gt;, oesophageal, prostate and other epithelial cancers [ 683874 ], [ 942804 ], [ 1204618 ], [ 1601884 ], [ 1644219 ], [ 1991498...expected that the development of the work would be undertaken by a licensing partner [ 1331002 ]; in December 2017, &lt;b&gt;Cancer&lt;/b&gt; Research UK agreed to conduct a UK-based phase I/II clinical trial of SCIB-2 in combination with a checkpoint inhibitor</Summary><ActionsSecondary><Action>Anticancer</Action><Action>DNA vaccine</Action><Action>Therapeutic vaccine</Action><Action>Vascular damaging agent</Action></ActionsSecondary><AddedDate>2006-08-15T00:00:00Z</AddedDate></Drug><Drug id="24064" name="rV-NY-ESO-1/rF-NY-ESO-1 prime-boost breast cancer vaccine, Ludwig Institute/Therion" lastModificationDate="2017-08-07T00:00:00Z" phaseHighest="No Development Reported"><CompanyOriginator>Ludwig Institute for Cancer Research (US)</CompanyOriginator><ActionsPrimary><Action>Cancer testis antigen NY-ESO-1 modulator</Action></ActionsPrimary><Technologies><Technology>Biological therapeutic</Technology><Technology>Subcutaneous formulation</Technology><Technology>Virus recombinant</Technology></Technologies><Summary>for &lt;b&gt;Cancer&lt;/b&gt; Research (LICR) and Therion Biologics were developing a pox virus vector vaccine expressing the NY-ESO-1 tumor-associated antigen for the potential treatment of breast &lt;b&gt;cancer&lt;/b&gt; [ 387199 ], [ 434718 ]. The vaccine was being developed...carried out by LICR were released in 2003 [ 491601 ], [ 515317 ]. In early 2004, investigator-led phase I trials in breast &lt;b&gt;cancer&lt;/b&gt; were ongoing [ 528184 ]; at that time, Therion had not yet taken the vaccine into its own internal pipeline [ 528184 ], [ 529517</Summary><CompaniesSecondary><Company>Ludwig Institute for Cancer Research (US)</Company><Company>Sanofi Pasteur</Company><Company>Therion Biologics Corp</Company></CompaniesSecondary><IndicationsSecondary><Indication>Breast tumor</Indication><Indication>Cancer</Indication></IndicationsSecondary><ActionsSecondary><Action>Anticancer</Action><Action>Recombinant viral vector vaccine</Action><Action>Therapeutic vaccine</Action></ActionsSecondary><AddedDate>1999-06-25T00:00:00Z</AddedDate></Drug><Drug id="100554" name="T-cell receptor mimic mABs (cancer), Xencor" lastModificationDate="2019-05-30T00:00:00Z" phaseHighest="Discovery"><CompanyOriginator>Xencor Inc</CompanyOriginator><CompaniesPrimary><Company>Xencor Inc</Company></CompaniesPrimary><IndicationsPrimary><Indication>Cancer</Indication></IndicationsPrimary><ActionsPrimary><Action>Cancer testis antigen NY-ESO-1 modulator</Action></ActionsPrimary><Technologies><Technology>Biological therapeutic</Technology><Technology>Monoclonal antibody</Technology></Technologies><Summary>Xencor is investigating T-Cell Receptor Mimic (TCRm) monoclonal antibodies which target &lt;b&gt;cancer&lt;/b&gt; testis antigen NY-ESO1, for the potential treatment of &lt;b&gt;cancer&lt;/b&gt; [ 1726823 ]. The program is under license from Receptor Logic specifically to target NY-ESO1 [ 1726823 ].</Summary><CompaniesSecondary><Company>Receptor Logic Inc</Company></CompaniesSecondary><ActionsSecondary><Action>Anticancer monoclonal antibody</Action></ActionsSecondary><AddedDate>2016-01-13T00:00:00Z</AddedDate></Drug><Drug id="112776" name="hematopoietic stem cell-derived anti-NY-ESO-1/HLA-DP4 TCR T-cell therapy + anti-NY-ESO-1/HLA-A*0201 TCR T-cell therapy (ovarian/fallopian tube/primary peritoneal cancer), Roswell Park Comprehensive Cancer Center" lastModificationDate="2019-01-29T00:00:00Z" phaseHighest="Phase 1 Clinical"><CompanyOriginator>Roswell Park Comprehensive Cancer Center</CompanyOriginator><CompaniesPrimary><Company>Roswell Park Comprehensive Cancer Center</Company></CompaniesPrimary><IndicationsPrimary><Indication>Fallopian tube cancer</Indication><Indication>Ovary tumor</Indication><Indication>Peritoneal tumor</Indication></IndicationsPrimary><ActionsPrimary><Action>Cancer testis antigen NY-ESO-1 modulator</Action><Action>HLA class I antigen A-2 alpha modulator</Action><Action>HLA class II antigen modulator</Action></ActionsPrimary><Technologies><Technology>Autologous stem cell therapy</Technology><Technology>Biological therapeutic</Technology><Technology>Haematopoietic stem cell therapy</Technology><Technology>Immuno-oncology</Technology><Technology>Infusion</Technology><Technology>Intravenous formulation</Technology><Technology>Protein recombinant</Technology><Technology>T-lymphocyte</Technology><Technology>T-lymphocyte cell therapy</Technology></Technologies><Summary>CD8 TCR specific for NY-ESO-1 in the context of HLA-A*0201, for the potential treatment of ovarian, fallopian tube and primary peritoneal &lt;b&gt;cancer&lt;/b&gt; [ 2080080 ]. In January 2019, a phase I trial in recurrent...or primary peritoneal &lt;b&gt;cancer&lt;/b&gt; was initiated [ 2080080 ]. Roswell is also developing an anti-NY-ESO-1/HLA-A*0201 TCR T-cell therapy + dnTGFbetaRII tumor infiltrating lymphocyte therapy for the potential treatment of &lt;b&gt;cancer&lt;/b&gt;.</Summary><ActionsSecondary><Action>Anticancer</Action><Action>Genetically engineered autologous cell therapy</Action><Action>Immunostimulant</Action><Action>T-lymphocyte stimulator</Action></ActionsSecondary><AddedDate>2018-10-22T00:00:00Z</AddedDate></Drug><Drug id="88864" name="NY-ESO-1-specific autologous CD8+ T-cell therapy (sarcoma), Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium/National Cancer Institute" lastModificationDate="2017-11-13T00:00:00Z" phaseHighest="No Development Reported"><CompanyOriginator>Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium</CompanyOriginator><ActionsPrimary><Action>Cancer testis antigen NY-ESO-1 modulator</Action></ActionsPrimary><Technologies><Technology>Biological therapeutic</Technology><Technology>Parenteral formulation unspecified</Technology><Technology>Systemic formulation unspecified</Technology><Technology>T-lymphocyte</Technology></Technologies><Summary>As no development has been reported for some time, this program is assumed to be discontinued. Fred Hutchinson &lt;b&gt;Cancer&lt;/b&gt; Research Center/University of Washington &lt;b&gt;Cancer&lt;/b&gt; Consortium in collaboration with National &lt;b&gt;Cancer&lt;/b&gt; Institute , was developing NY-ESO-1-specific, autologous CD8+ T-cell therapy for the potential treatment of soft tissue sarcoma including round cell liposarcoma and synovial sarcoma. In January 2012, a phase I trial began and in August 2013, the trial was ongoing [ 1504974 ]. In December</Summary><CompaniesSecondary><Company>Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium</Company><Company>National Cancer Institute</Company></CompaniesSecondary><IndicationsSecondary><Indication>Soft tissue sarcoma</Indication></IndicationsSecondary><ActionsSecondary><Action>Anticancer</Action><Action>Immunostimulant</Action></ActionsSecondary><AddedDate>2013-12-04T00:00:00Z</AddedDate></Drug><Drug id="64055" name="GSK-3377794" lastModificationDate="2018-12-05T00:00:00Z" phaseHighest="Phase 2 Clinical"><CompanyOriginator>Adaptimmune Therapeutics plc</CompanyOriginator><CompaniesPrimary><Company>GlaxoSmithKline plc</Company></CompaniesPrimary><RegulatoryDesignations><RegulatoryDesignation>Breakthrough Therapy</RegulatoryDesignation><RegulatoryDesignation>Orphan Drug</RegulatoryDesignation><RegulatoryDesignation>PRIME</RegulatoryDesignation></RegulatoryDesignations><IndicationsPrimary><Indication>Liposarcoma</Indication><Indication>Metastatic non small cell lung cancer</Indication><Indication>Multiple myeloma</Indication><Indication>Ovary tumor</Indication><Indication>Soft tissue sarcoma</Indication></IndicationsPrimary><ActionsPrimary><Action>Cancer testis antigen NY-ESO-1 modulator</Action><Action>HLA class I antigen A-2 alpha modulator</Action></ActionsPrimary><Technologies><Technology>Biological therapeutic</Technology><Technology>Immuno-oncology</Technology><Technology>Infusion</Technology><Technology>Intravenous formulation</Technology><Technology>Protein recombinant</Technology><Technology>T-lymphocyte</Technology><Technology>T-lymphocyte cell therapy</Technology></Technologies><Summary>of &lt;b&gt;cancer&lt;/b&gt;, including metastatic non small cell lung &lt;b&gt;cancer&lt;/b&gt; (NSCLC), multiple myeloma (MM), synovial&amp;nbsp;sarcoma...was ongoing for MM [ 2059415 ]. In June 2013, a phase I/II ovarian &lt;b&gt;cancer&lt;/b&gt; trial began [ 1277243 ]. In September 2017, following development transition to GSK, Adaptimmune...other &lt;b&gt;cancer&lt;/b&gt; indications. In March 2015, the program was in phase I/II development for esophageal &lt;b&gt;cancer&lt;/b&gt; [ 1643152 ]. However no further development for that</Summary><CompaniesSecondary><Company>Adaptimmune Therapeutics plc</Company></CompaniesSecondary><IndicationsSecondary><Indication>Cancer</Indication><Indication>Esophagus tumor</Indication><Indication>Melanoma</Indication></IndicationsSecondary><ActionsSecondary><Action>Anticancer</Action><Action>Genetically engineered autologous cell therapy</Action><Action>Immunostimulant</Action><Action>T-lymphocyte stimulator</Action></ActionsSecondary><AddedDate>2009-07-24T00:00:00Z</AddedDate></Drug></SearchResults><Filters total="15"><Filter label="Drug Sales 2010 (USD M)" name="drugSalesYearActual" total="5"><FilterOption count="413" label="&lt; 100"></FilterOption><FilterOption count="68" label="≥ 100 and  250"></FilterOption><FilterOption count="54" label="≥ 250 and  500"></FilterOption><FilterOption count="43" label="≥ 500 and  1000"></FilterOption><FilterOption count="84" label="≥ 1000"></FilterOption></Filter><Filter label="Secondary Actions" name="actionsSecondary" total="100"><FilterOption id="1545" count="15609" label="Anticancer"></FilterOption><FilterOption id="62255" count="3227" label="Anticancer protein kinase inhibitor"></FilterOption><FilterOption id="59620" count="2993" label="Unspecified drug target"></FilterOption><FilterOption id="393" count="2412" label="Immunostimulant"></FilterOption><FilterOption id="55685" count="2400" label="Anticancer monoclonal antibody"></FilterOption><FilterOption id="7761" count="1736" label="T-lymphocyte stimulator"></FilterOption><FilterOption id="2953" count="1505" label="Anti-inflammatory"></FilterOption><FilterOption id="1589" count="1441" label="Apoptosis stimulator"></FilterOption><FilterOption id="12379" count="1382" label="Therapeutic vaccine"></FilterOption><FilterOption id="55684" count="1339" label="Anticancer antibody"></FilterOption><FilterOption id="61" count="1067" label="Angiogenesis inhibitor"></FilterOption><FilterOption id="1596" count="832" label="Immunomodulator"></FilterOption><FilterOption id="991" count="794" label="Antiviral"></FilterOption><FilterOption id="767" count="701" label="Cell cycle inhibitor"></FilterOption><FilterOption id="7220" count="681" label="Neoplasm diagnostic agent"></FilterOption><FilterOption id="4790" count="524" label="Genetically engineered autologous cell therapy"></FilterOption><FilterOption id="7293" count="408" label="Synergist"></FilterOption><FilterOption id="4155" count="379" label="Imaging agent"></FilterOption><FilterOption id="2946" count="378" label="Analgesic"></FilterOption><FilterOption id="695" count="335" label="Metastasis inhibitor"></FilterOption><FilterOption id="1615" count="303" label="Neuroprotectant"></FilterOption><FilterOption id="50" count="301" label="Anticancer alkylating agent"></FilterOption><FilterOption id="2575" count="298" label="Microtubule inhibitor"></FilterOption><FilterOption id="5720" count="274" label="Radiodiagnostic"></FilterOption><FilterOption id="539" count="256" label="Immunotoxin"></FilterOption><FilterOption id="12372" count="249" label="Protein subunit vaccine"></FilterOption><FilterOption id="2576" count="225" label="Microtubule stabilizer"></FilterOption><FilterOption id="5555" count="219" label="PET contrast agent"></FilterOption><FilterOption id="26035" count="215" label="siRNA agent"></FilterOption><FilterOption id="399" count="214" label="Hypoglycemic agent"></FilterOption><FilterOption id="7294" count="207" label="Antisense oligonucleotide inhibitor"></FilterOption><FilterOption id="1594" count="205" label="Antibacterial"></FilterOption><FilterOption id="4780" count="196" label="Adenovirus based gene therapy"></FilterOption><FilterOption id="102926" count="188" label="Dendritic cell vaccine"></FilterOption><FilterOption id="7757" count="186" label="Natural killer cell stimulator"></FilterOption><FilterOption id="12378" count="178" label="Prophylactic vaccine"></FilterOption><FilterOption id="750" count="170" label="DNA intercalator"></FilterOption><FilterOption id="140" count="169" label="DNA synthesis inhibitor"></FilterOption><FilterOption id="7212" count="158" label="Endocrine diagnostic agent"></FilterOption><FilterOption id="62254" count="155" label="Anticancer hormone antagonist"></FilterOption><FilterOption id="15184" count="154" label="Systemic antipsoriatic product"></FilterOption><FilterOption id="1879" count="153" label="DNA vaccine"></FilterOption><FilterOption id="12370" count="150" label="Recombinant viral vector vaccine"></FilterOption><FilterOption id="396" count="146" label="Immunosuppressant"></FilterOption><FilterOption id="7751" count="142" label="Macrophage stimulator"></FilterOption><FilterOption id="610" count="140" label="Hematopoietic stimulator"></FilterOption><FilterOption id="524" count="139" label="Adjuvant"></FilterOption><FilterOption id="62253" count="139" label="Anticancer hormone"></FilterOption><FilterOption id="5721" count="139" label="Radiotherapeutic"></FilterOption><FilterOption id="1569" count="135" label="Anticancer antimetabolite"></FilterOption><FilterOption id="1552" count="132" label="Radioimmunotherapeutic"></FilterOption><FilterOption id="1586" count="126" label="Anticancer chemosensitizer"></FilterOption><FilterOption id="759" count="112" label="Anticancer multidrug resistance inhibitor"></FilterOption><FilterOption id="173472" count="112" label="Dendritic cell stimulator"></FilterOption><FilterOption id="2657" count="108" label="Antihypertensive"></FilterOption><FilterOption id="799" count="105" label="Photosensitizer"></FilterOption><FilterOption id="7213" count="104" label="Gastrointestinal diagnostic agent"></FilterOption><FilterOption id="1593" count="101" label="Antimicrobial"></FilterOption><FilterOption id="2660" count="94" label="Vasoprotectant"></FilterOption><FilterOption id="1748" count="86" label="Fungicide"></FilterOption><FilterOption id="4791" count="86" label="Genetically engineered autologous cell vaccine"></FilterOption><FilterOption id="1542" count="86" label="Radiosensitizer"></FilterOption><FilterOption id="38419" count="83" label="miRNA agent"></FilterOption><FilterOption id="15128" count="77" label="Ophthalmological agent"></FilterOption><FilterOption id="74" count="76" label="Antioxidant agent"></FilterOption><FilterOption id="4778" count="76" label="Gene therapy"></FilterOption><FilterOption id="2969" count="76" label="Vascular damaging agent"></FilterOption><FilterOption id="965" count="70" label="Cardiovascular agent"></FilterOption><FilterOption id="664" count="68" label="Fibrosuppressant"></FilterOption><FilterOption id="89" count="67" label="Bone resorption inhibitor"></FilterOption><FilterOption id="2955" count="67" label="Non-steroidal anti-inflammatory"></FilterOption><FilterOption id="7292" count="67" label="Vulnerary agent"></FilterOption><FilterOption id="1276" count="65" label="Chemoprotectant"></FilterOption><FilterOption id="803" count="65" label="DNA modulator"></FilterOption><FilterOption id="3272" count="65" label="Growth hormone release inhibitor"></FilterOption><FilterOption id="2970" count="63" label="Anti-emetic"></FilterOption><FilterOption id="4405" count="63" label="Radioimmunodiagnostic"></FilterOption><FilterOption id="1465" count="61" label="Radioprotectant"></FilterOption><FilterOption id="7747" count="60" label="Leukocyte stimulator"></FilterOption><FilterOption id="339" count="60" label="Protein synthesis inhibitor"></FilterOption><FilterOption id="2947" count="59" label="Antiparkinsonian"></FilterOption><FilterOption id="2638" count="58" label="Antiparasitic"></FilterOption><FilterOption id="7741" count="57" label="B-lymphocyte stimulator"></FilterOption><FilterOption id="7210" count="56" label="Cardiovascular diagnostic agent"></FilterOption><FilterOption id="4782" count="56" label="Retrovirus based gene therapy"></FilterOption><FilterOption id="4792" count="56" label="Unspecified vector based gene therapy"></FilterOption><FilterOption id="284" count="54" label="Nootropic agent"></FilterOption><FilterOption id="5692" count="53" label="T-lymphocyte modulator"></FilterOption><FilterOption id="1585" count="52" label="Bioreducible cytotoxin"></FilterOption><FilterOption id="2667" count="50" label="Antiarteriosclerotic"></FilterOption><FilterOption id="1332" count="48" label="Gastrointestinal system agent"></FilterOption><FilterOption id="4158" count="48" label="MRI imaging agent"></FilterOption><FilterOption id="2659" count="47" label="Cardioprotectant"></FilterOption><FilterOption id="53558" count="47" label="Stem cell modulator"></FilterOption><FilterOption id="15148" count="46" label="Ocular antineovascularisation agent"></FilterOption><FilterOption id="794" count="46" label="Oncogene inhibitor"></FilterOption><FilterOption id="53560" count="46" label="Stem cell inhibitor"></FilterOption><FilterOption id="1590" count="45" label="Apoptosis inhibitor"></FilterOption><FilterOption id="1588" count="45" label="Apoptosis modulator"></FilterOption><FilterOption id="7211" count="45" label="CNS diagnostic agent"></FilterOption></Filter><Filter label="Drug Deal Types" name="drugDealTypes" total="20"><FilterOption id="4" count="3719" label="Drug - Development/Commercialization License"></FilterOption><FilterOption id="3" count="2329" label="Drug - Early Research/Development"></FilterOption><FilterOption id="13" count="2080" label="Drug - Funding"></FilterOption><FilterOption id="7" count="990" label="Drug - Development Services"></FilterOption><FilterOption id="10" count="797" label="Technology - Other Proprietary"></FilterOption><FilterOption id="6" count="716" label="Drug - Manufacturing/Supply"></FilterOption><FilterOption id="5" count="620" label="Drug - Commercialization License"></FilterOption><FilterOption id="11" count="510" label="Patent - Exclusive Rights"></FilterOption><FilterOption id="2" count="470" label="Drug - Screening/Evaluation"></FilterOption><FilterOption id="14" count="315" label="Drug - Asset Divestment"></FilterOption><FilterOption id="8" count="275" label="Technology - Delivery/Formulation"></FilterOption><FilterOption id="1" count="210" label="Drug - Discovery/Design"></FilterOption><FilterOption id="15" count="181" label="Drug - CRADA"></FilterOption><FilterOption id="20" count="124" label="Company - M&amp;A (in whole or part)"></FilterOption><FilterOption id="12" count="82" label="Patent - Non-Exclusive Rights"></FilterOption><FilterOption id="19" count="49" label="Company - Joint Venture"></FilterOption><FilterOption id="17" count="25" label="Patent - Asset Divestment"></FilterOption><FilterOption id="21" count="18" label="Patent - Litigation Settlement"></FilterOption><FilterOption id="16" count="18" label="Technology - Asset Divestment"></FilterOption><FilterOption id="9" count="15" label="Technology - Target Validation"></FilterOption></Filter><Filter label="Drug Forecast 2015 (USD M)" name="drugSalesYearEstimate" total="5"><FilterOption count="243" label="&lt; 100"></FilterOption><FilterOption count="77" label="≥ 100 and  250"></FilterOption><FilterOption count="66" label="≥ 250 and  500"></FilterOption><FilterOption count="50" label="≥ 500 and  1000"></FilterOption><FilterOption count="92" label="≥ 1000"></FilterOption></Filter><Filter label="Drug Deals Count" name="drugDealsCount" total="8"><FilterOption count="15620" label="= 0"></FilterOption><FilterOption count="5242" label="&gt; 1 and ≤ 1"></FilterOption><FilterOption count="1608" label="&gt; 2 and ≤ 2"></FilterOption><FilterOption count="680" label="&gt; 3 and ≤ 3"></FilterOption><FilterOption count="372" label="&gt; 4 and ≤ 4"></FilterOption><FilterOption count="209" label="&gt; 5 and ≤ 5"></FilterOption><FilterOption count="405" label="&gt; 6 and ≤ 10"></FilterOption><FilterOption count="123" label="&gt; 11"></FilterOption></Filter><Filter label="Technologies" name="technologies" total="100"><FilterOption id="762" count="13101" label="Small molecule therapeutic"></FilterOption><FilterOption id="761" count="10373" label="Biological therapeutic"></FilterOption><FilterOption id="766" count="4341" label="Parenteral formulation unspecified"></FilterOption><FilterOption id="648" count="3071" label="Intravenous formulation"></FilterOption><FilterOption id="585" count="2842" label="Oral formulation"></FilterOption><FilterOption id="1263" count="2297" label="Immuno-oncology"></FilterOption><FilterOption id="740" count="1865" label="Infusion"></FilterOption><FilterOption id="80" count="1560" label="Peptide"></FilterOption><FilterOption id="85" count="1383" label="Protein recombinant"></FilterOption><FilterOption id="84" count="1116" label="Protein fusion"></FilterOption><FilterOption id="169" count="835" label="Monoclonal antibody humanized"></FilterOption><FilterOption id="1647" count="766" label="Natural product"></FilterOption><FilterOption id="51" count="758" label="Monoclonal antibody"></FilterOption><FilterOption id="135" count="715" label="T-lymphocyte"></FilterOption><FilterOption id="647" count="647" label="Subcutaneous formulation"></FilterOption><FilterOption id="595" count="623" label="Tablet formulation"></FilterOption><FilterOption id="731" count="610" label="Imaging"></FilterOption><FilterOption id="603" count="608" label="Systemic formulation unspecified"></FilterOption><FilterOption id="1" count="601" label="Antibody"></FilterOption><FilterOption id="168" count="600" label="Monoclonal antibody human"></FilterOption><FilterOption id="573" count="548" label="Immunoglobulin-G"></FilterOption><FilterOption id="586" count="545" label="Capsule formulation"></FilterOption><FilterOption id="345" count="545" label="Receptor chimeric"></FilterOption><FilterOption id="62" count="526" label="Virus recombinant"></FilterOption><FilterOption id="570" count="521" label="Cell therapy"></FilterOption><FilterOption id="1247" count="518" label="Chimeric antigen receptor T cell therapy"></FilterOption><FilterOption id="1668" count="511" label="Nanoparticle formulation"></FilterOption><FilterOption id="175" count="481" label="Drug combination"></FilterOption><FilterOption id="103" count="481" label="Oligonucleotide"></FilterOption><FilterOption id="724" count="407" label="Radiolabeling"></FilterOption><FilterOption id="596" count="397" label="Injectable formulation"></FilterOption><FilterOption id="171" count="374" label="Monoclonal antibody conjugated"></FilterOption><FilterOption id="1652" count="365" label="Prodrug"></FilterOption><FilterOption id="962" count="355" label="Biosimilar product"></FilterOption><FilterOption id="267" count="312" label="Multivalent antibody"></FilterOption><FilterOption id="216" count="305" label="Antibody conjugated"></FilterOption><FilterOption id="180" count="284" label="Antibody fragment"></FilterOption><FilterOption id="1164" count="259" label="Antibody drug conjugate"></FilterOption><FilterOption id="142" count="257" label="Liposome formulation"></FilterOption><FilterOption id="569" count="257" label="Oligonucleotide antisense"></FilterOption><FilterOption id="207" count="253" label="Protein conjugated"></FilterOption><FilterOption id="599" count="246" label="Nanoparticle formulation injectable"></FilterOption><FilterOption id="347" count="244" label="Intratumoral formulation"></FilterOption><FilterOption id="589" count="237" label="Sustained release formulation"></FilterOption><FilterOption id="651" count="210" label="Intramuscular formulation"></FilterOption><FilterOption id="170" count="210" label="Multivalent monoclonal antibody"></FilterOption><FilterOption id="166" count="201" label="Chimeric monoclonal antibody"></FilterOption><FilterOption id="746" count="195" label="Solution"></FilterOption><FilterOption id="611" count="186" label="Dermatological formulation"></FilterOption><FilterOption id="348" count="182" label="PEGylated formulation"></FilterOption><FilterOption id="1653" count="178" label="Tumor antigen"></FilterOption><FilterOption id="538" count="170" label="Humanized antibody"></FilterOption><FilterOption id="1655" count="154" label="Tumor antigen therapeutic"></FilterOption><FilterOption id="93" count="139" label="Toxin"></FilterOption><FilterOption id="66" count="127" label="Antibiotic"></FilterOption><FilterOption id="851" count="127" label="Intradermal formulation"></FilterOption><FilterOption id="1246" count="125" label="T-lymphocyte cell therapy"></FilterOption><FilterOption id="961" count="115" label="Follow on biological product"></FilterOption><FilterOption id="751" count="110" label="Film coating"></FilterOption><FilterOption id="558" count="108" label="Transdermal formulation"></FilterOption><FilterOption id="667" count="105" label="Peptidomimetic"></FilterOption><FilterOption id="67" count="98" label="Antigen"></FilterOption><FilterOption id="750" count="97" label="Freeze drying"></FilterOption><FilterOption id="898" count="92" label="Formulation powder"></FilterOption><FilterOption id="598" count="86" label="Liposome formulation injectable"></FilterOption><FilterOption id="215" count="84" label="Antigen presentation system"></FilterOption><FilterOption id="74" count="83" label="Glycoprotein"></FilterOption><FilterOption id="349" count="81" label="Lipid"></FilterOption><FilterOption id="641" count="78" label="Controlled release formulation"></FilterOption><FilterOption id="159" count="74" label="Oligosaccharide"></FilterOption><FilterOption id="649" count="72" label="Intraperitoneal formulation"></FilterOption><FilterOption id="56" count="71" label="Bacteria recombinant"></FilterOption><FilterOption id="90" count="69" label="Steroid"></FilterOption><FilterOption id="616" count="68" label="Inhalant formulation"></FilterOption><FilterOption id="1672" count="65" label="Directed prodrug therapy"></FilterOption><FilterOption id="130" count="55" label="Lymphocyte"></FilterOption><FilterOption id="1245" count="55" label="Lymphocyte cell therapy"></FilterOption><FilterOption id="167" count="55" label="Monoclonal antibody murine"></FilterOption><FilterOption id="745" count="55" label="Suspension"></FilterOption><FilterOption id="593" count="54" label="Oral liquid formulation"></FilterOption><FilterOption id="102" count="50" label="Nucleotide and derivatives"></FilterOption><FilterOption id="620" count="48" label="Ophthalmic formulation"></FilterOption><FilterOption id="901" count="48" label="Recombinant enzyme"></FilterOption><FilterOption id="1646" count="47" label="Injectable controlled release formulation"></FilterOption><FilterOption id="72" count="46" label="Enzyme"></FilterOption><FilterOption id="83" count="46" label="Protein chimeric"></FilterOption><FilterOption id="852" count="45" label="Intravesical formulation"></FilterOption><FilterOption id="594" count="45" label="Oral suspension formulation"></FilterOption><FilterOption id="660" count="45" label="Oral sustained release formulation"></FilterOption><FilterOption id="755" count="44" label="Stem cell therapy"></FilterOption><FilterOption id="680" count="42" label="Buccal formulation systemic"></FilterOption><FilterOption id="112" count="42" label="DNA technology"></FilterOption><FilterOption id="764" count="42" label="Local formulation unspecified"></FilterOption><FilterOption id="753" count="42" label="Microparticle formulation"></FilterOption><FilterOption id="894" count="41" label="Liquid formulation"></FilterOption><FilterOption id="559" count="41" label="Oral controlled release formulation"></FilterOption><FilterOption id="537" count="39" label="Chimeric antibody"></FilterOption><FilterOption id="612" count="37" label="Emulsion dermatological"></FilterOption><FilterOption id="1671" count="36" label="Gene directed enzyme prodrug therapy"></FilterOption><FilterOption id="884" count="36" label="Haematopoietic stem cell therapy"></FilterOption></Filter><Filter label="Drug Added by Day" name="drugAddedDateByDay" total="100"><FilterOption count="1616" label="1996-02-16"></FilterOption><FilterOption count="179" label="2016-10-27"></FilterOption><FilterOption count="160" label="2019-01-08"></FilterOption><FilterOption count="148" label="2015-08-01"></FilterOption><FilterOption count="140" label="2015-05-13"></FilterOption><FilterOption count="116" label="2014-04-09"></FilterOption><FilterOption count="98" label="2016-08-31"></FilterOption><FilterOption count="89" label="2017-04-18"></FilterOption><FilterOption count="85" label="2018-05-02"></FilterOption><FilterOption count="79" label="2016-12-20"></FilterOption><FilterOption count="77" label="2018-03-20"></FilterOption><FilterOption count="77" label="2018-05-11"></FilterOption><FilterOption count="72" label="2017-11-06"></FilterOption><FilterOption count="71" label="2015-04-29"></FilterOption><FilterOption count="70" label="2015-05-14"></FilterOption><FilterOption count="65" label="2015-10-22"></FilterOption><FilterOption count="61" label="2019-05-13"></FilterOption><FilterOption count="55" label="2013-10-18"></FilterOption><FilterOption count="55" label="2013-12-04"></FilterOption><FilterOption count="54" label="2017-01-02"></FilterOption><FilterOption count="49" label="2013-10-30"></FilterOption><FilterOption count="48" label="2017-12-26"></FilterOption><FilterOption count="46" label="2016-06-04"></FilterOption><FilterOption count="45" label="2014-12-06"></FilterOption><FilterOption count="43" label="2016-10-24"></FilterOption><FilterOption count="41" label="2014-09-18"></FilterOption><FilterOption count="41" label="2019-06-16"></FilterOption><FilterOption count="40" label="2016-05-04"></FilterOption><FilterOption count="40" label="2017-04-21"></FilterOption><FilterOption count="40" label="2018-06-11"></FilterOption><FilterOption count="38" label="2017-09-18"></FilterOption><FilterOption count="37" label="2019-05-02"></FilterOption><FilterOption count="36" label="2019-03-16"></FilterOption><FilterOption count="35" label="2017-01-30"></FilterOption><FilterOption count="35" label="2017-03-01"></FilterOption><FilterOption count="34" label="2015-06-22"></FilterOption><FilterOption count="34" label="2016-06-27"></FilterOption><FilterOption count="34" label="2017-01-11"></FilterOption><FilterOption count="34" label="2019-05-30"></FilterOption><FilterOption count="33" label="2015-09-09"></FilterOption><FilterOption count="33" label="2016-04-21"></FilterOption><FilterOption count="33" label="2016-09-29"></FilterOption><FilterOption count="33" label="2018-09-11"></FilterOption><FilterOption count="32" label="2016-05-26"></FilterOption><FilterOption count="32" label="2016-09-27"></FilterOption><FilterOption count="32" label="2018-05-03"></FilterOption><FilterOption count="31" label="2015-06-18"></FilterOption><FilterOption count="31" label="2015-11-23"></FilterOption><FilterOption count="30" label="2013-11-29"></FilterOption><FilterOption count="30" label="2018-02-05"></FilterOption><FilterOption count="29" label="2015-12-08"></FilterOption><FilterOption count="29" label="2017-11-13"></FilterOption><FilterOption count="29" label="2017-12-21"></FilterOption><FilterOption count="28" label="2013-07-17"></FilterOption><FilterOption count="28" label="2016-12-26"></FilterOption><FilterOption count="28" label="2017-04-06"></FilterOption><FilterOption count="27" label="2013-11-07"></FilterOption><FilterOption count="27" label="2013-11-28"></FilterOption><FilterOption count="27" label="2016-12-07"></FilterOption><FilterOption count="26" label="2016-04-29"></FilterOption><FilterOption count="25" label="2010-11-04"></FilterOption><FilterOption count="25" label="2013-04-26"></FilterOption><FilterOption count="25" label="2016-07-15"></FilterOption><FilterOption count="25" label="2017-06-09"></FilterOption><FilterOption count="25" label="2017-12-11"></FilterOption><FilterOption count="25" label="2019-04-29"></FilterOption><FilterOption count="24" label="2017-01-12"></FilterOption><FilterOption count="24" label="2017-08-21"></FilterOption><FilterOption count="24" label="2017-10-25"></FilterOption><FilterOption count="23" label="1996-09-13"></FilterOption><FilterOption count="23" label="2013-04-09"></FilterOption><FilterOption count="22" label="2010-08-18"></FilterOption><FilterOption count="22" label="2012-04-05"></FilterOption><FilterOption count="22" label="2013-08-30"></FilterOption><FilterOption count="22" label="2015-11-17"></FilterOption><FilterOption count="22" label="2016-05-07"></FilterOption><FilterOption count="22" label="2016-06-15"></FilterOption><FilterOption count="22" label="2016-11-21"></FilterOption><FilterOption count="22" label="2017-10-24"></FilterOption><FilterOption count="21" label="2015-09-29"></FilterOption><FilterOption count="21" label="2015-11-28"></FilterOption><FilterOption count="21" label="2016-05-23"></FilterOption><FilterOption count="21" label="2017-01-04"></FilterOption><FilterOption count="20" label="2001-04-04"></FilterOption><FilterOption count="20" label="2008-04-23"></FilterOption><FilterOption count="20" label="2012-08-29"></FilterOption><FilterOption count="19" label="1996-04-30"></FilterOption><FilterOption count="19" label="2012-08-24"></FilterOption><FilterOption count="19" label="2013-12-10"></FilterOption><FilterOption count="19" label="2015-09-11"></FilterOption><FilterOption count="19" label="2016-03-22"></FilterOption><FilterOption count="19" label="2017-04-27"></FilterOption><FilterOption count="18" label="2012-07-13"></FilterOption><FilterOption count="18" label="2013-12-12"></FilterOption><FilterOption count="18" label="2014-04-17"></FilterOption><FilterOption count="18" label="2017-10-12"></FilterOption><FilterOption count="18" label="2019-02-21"></FilterOption><FilterOption count="17" label="2015-06-28"></FilterOption><FilterOption count="16" label="1996-07-30"></FilterOption><FilterOption count="15" label="2013-11-13"></FilterOption></Filter><Filter label="Drug Has Financials" name="drugHasFinancials" total="2"><FilterOption count="23618" label="No"></FilterOption><FilterOption count="641" label="Yes"></FilterOption></Filter><Filter label="Secondary Companies" name="companiesSecondary" total="100"><FilterOption id="20519" count="333" label="National Cancer Institute"></FilterOption><FilterOption id="20518" count="253" label="National Institutes of Health"></FilterOption><FilterOption id="18767" count="219" label="Pfizer Inc"></FilterOption><FilterOption id="17002" count="179" label="Human Genome Sciences Inc"></FilterOption><FilterOption id="15065" count="164" label="Bristol-Myers Squibb Co"></FilterOption><FilterOption id="23137" count="127" label="Novartis AG"></FilterOption><FilterOption id="17810" count="119" label="Eli Lilly &amp; Co"></FilterOption><FilterOption id="28355" count="119" label="GlaxoSmithKline plc"></FilterOption><FilterOption id="14190" count="118" label="AstraZeneca plc"></FilterOption><FilterOption id="18077" count="115" label="Merck &amp; Co Inc"></FilterOption><FilterOption id="13601" count="114" label="Abbott Laboratories"></FilterOption><FilterOption id="14109" count="107" label="Amgen Inc"></FilterOption><FilterOption id="19446" count="101" label="Roche Holding AG"></FilterOption><FilterOption id="19453" count="97" label="Genentech Inc"></FilterOption><FilterOption id="1009547" count="88" label="Sanofi SA"></FilterOption><FilterOption id="22122" count="87" label="Memorial Sloan-Kettering Cancer Center"></FilterOption><FilterOption id="23382" count="82" label="MD Anderson Cancer Center"></FilterOption><FilterOption id="14455" count="78" label="Bayer AG"></FilterOption><FilterOption id="20300" count="72" label="Takeda Pharmaceutical Co Ltd"></FilterOption><FilterOption id="19687" count="71" label="Bayer Schering Pharma AG"></FilterOption><FilterOption id="17724" count="70" label="Kyowa Hakko Kogyo Co Ltd"></FilterOption><FilterOption id="19711" count="70" label="Schering-Plough Corp"></FilterOption><FilterOption id="20596" count="68" label="Johns Hopkins University"></FilterOption><FilterOption id="18008" count="62" label="MedImmune LLC"></FilterOption><FilterOption id="15331" count="58" label="Celgene Corp"></FilterOption><FilterOption id="15414" count="57" label="Chugai Pharmaceutical Co Ltd"></FilterOption><FilterOption id="17204" count="57" label="Immunomedics Inc"></FilterOption><FilterOption id="29469" count="55" label="Cancer Research UK"></FilterOption><FilterOption id="16453" count="54" label="Glaxo Group Ltd"></FilterOption><FilterOption id="30620" count="53" label="Cancer Research Technology Ltd"></FilterOption><FilterOption id="20659" count="52" label="University of Pittsburgh"></FilterOption><FilterOption id="15872" count="51" label="Eisai Co Ltd"></FilterOption><FilterOption id="14112" count="51" label="Wyeth"></FilterOption><FilterOption id="17808" count="50" label="Ligand Pharmaceuticals Inc"></FilterOption><FilterOption id="19862" count="50" label="Merck Serono SA"></FilterOption><FilterOption id="15615" count="49" label="Dana-Farber Cancer Institute Inc"></FilterOption><FilterOption id="20649" count="49" label="Ohio State University"></FilterOption><FilterOption id="17269" count="48" label="Ionis Pharmaceuticals Inc"></FilterOption><FilterOption id="20805" count="47" label="Parke-Davis &amp; Co"></FilterOption><FilterOption id="21991" count="45" label="Takeda Oncology"></FilterOption><FilterOption id="14881" count="44" label="Boehringer Ingelheim International GmbH"></FilterOption><FilterOption id="1013295" count="43" label="Astellas Pharma Inc"></FilterOption><FilterOption id="21885" count="43" label="Astex Pharmaceuticals Inc"></FilterOption><FilterOption id="17968" count="42" label="Medarex Inc"></FilterOption><FilterOption id="25520" count="41" label="University of Colorado System"></FilterOption><FilterOption id="1042596" count="40" label="Kyowa Hakko Kirin Co Ltd"></FilterOption><FilterOption id="17229" count="39" label="INSERM"></FilterOption><FilterOption id="22006" count="38" label="Pharmacia &amp; Upjohn Inc"></FilterOption><FilterOption id="25451" count="38" label="University of California San Diego"></FilterOption><FilterOption id="21072" count="37" label="Institute of Cancer Research UK"></FilterOption><FilterOption id="15511" count="36" label="Centre National de la Recherche Scientifique (CNRS)"></FilterOption><FilterOption id="15358" count="36" label="Cephalon Inc"></FilterOption><FilterOption id="20679" count="36" label="Stanford University"></FilterOption><FilterOption id="18720" count="36" label="Taiho Pharmaceutical Co Ltd"></FilterOption><FilterOption id="27638" count="35" label="Pharmacia Corp"></FilterOption><FilterOption id="20703" count="35" label="Yale University"></FilterOption><FilterOption id="26488" count="34" label="Agouron Pharmaceuticals Inc"></FilterOption><FilterOption id="15623" count="33" label="ASTA Medica AG"></FilterOption><FilterOption id="25623" count="33" label="University of California Los Angeles"></FilterOption><FilterOption id="15873" count="32" label="Elan Corp plc"></FilterOption><FilterOption id="16227" count="32" label="Fujisawa Pharmaceutical Co Ltd"></FilterOption><FilterOption id="17193" count="32" label="Imclone LLC"></FilterOption><FilterOption id="20658" count="32" label="University of Pennsylvania"></FilterOption><FilterOption id="16955" count="32" label="Zeneca Group plc"></FilterOption><FilterOption id="17661" count="31" label="Kirin Brewery Co Ltd"></FilterOption><FilterOption id="15336" count="31" label="UCB Celltech"></FilterOption><FilterOption id="20592" count="31" label="University of Illinois"></FilterOption><FilterOption id="20623" count="31" label="University of Michigan"></FilterOption><FilterOption id="20967" count="31" label="Yamanouchi Pharmaceutical Co Ltd"></FilterOption><FilterOption id="25902" count="30" label="Array BioPharma Inc"></FilterOption><FilterOption id="25218" count="30" label="Aventis Pharma AG"></FilterOption><FilterOption id="20534" count="30" label="Baylor College of Medicine"></FilterOption><FilterOption id="26864" count="30" label="Bristol-Myers Squibb Pharma Co"></FilterOption><FilterOption id="25224" count="30" label="Hoechst Marion Roussel Inc"></FilterOption><FilterOption id="18101" count="30" label="Merck KGaA"></FilterOption><FilterOption id="1020809" count="30" label="Micromet Inc"></FilterOption><FilterOption id="1034753" count="30" label="University of Colorado Technology Transfer Office"></FilterOption><FilterOption id="15385" count="29" label="Chiron Corp"></FilterOption><FilterOption id="22676" count="29" label="Exelixis Inc"></FilterOption><FilterOption id="29603" count="29" label="H Lee Moffitt Cancer Center and Research Institute"></FilterOption><FilterOption id="21102" count="29" label="Scripps Research Institute"></FilterOption><FilterOption id="20686" count="29" label="University of Tokyo"></FilterOption><FilterOption id="1005244" count="28" label="Biogen Inc"></FilterOption><FilterOption id="24437" count="28" label="Ciba-Geigy AG"></FilterOption><FilterOption id="16045" count="28" label="Enzon Pharmaceuticals Inc"></FilterOption><FilterOption id="18676" count="28" label="OSI Pharmaceuticals Inc"></FilterOption><FilterOption id="17927" count="28" label="PharmaMar SA"></FilterOption><FilterOption id="21159" count="28" label="Sigma-Tau Ind Farm Riunite SpA"></FilterOption><FilterOption id="19962" count="28" label="SmithKline Beecham plc"></FilterOption><FilterOption id="21091" count="27" label="Ludwig Institute for Cancer Research"></FilterOption><FilterOption id="24773" count="27" label="University of California San Francisco"></FilterOption><FilterOption id="23844" count="26" label="Deutsches Krebsforschungszentrum"></FilterOption><FilterOption id="26178" count="26" label="F Hoffmann-La Roche AG"></FilterOption><FilterOption id="25463" count="26" label="Hughes Institute"></FilterOption><FilterOption id="17259" count="26" label="Ipsen"></FilterOption><FilterOption id="20339" count="26" label="MabVax Therapeutics Holdings Inc"></FilterOption><FilterOption id="1013717" count="26" label="Nerviano Medical Sciences Srl"></FilterOption><FilterOption id="25314" count="26" label="Shanghai Institute of Materia Medica of the Chinese Academy of Sciences"></FilterOption><FilterOption id="1072507" count="25" label="AbbVie Inc"></FilterOption><FilterOption id="14042" count="25" label="Allergan Inc"></FilterOption></Filter><Filter label="Primary Indications" name="indicationsPrimary" total="100"><FilterOption id="651" count="4567" label="Cancer"></FilterOption><FilterOption id="725" count="905" label="Solid tumor"></FilterOption><FilterOption id="49" count="731" label="Breast tumor"></FilterOption><FilterOption id="3713" count="524" label="Advanced solid tumor"></FilterOption><FilterOption id="1262" count="418" label="Non-small-cell lung cancer"></FilterOption><FilterOption id="1731" count="396" label="Acute myelogenous leukemia"></FilterOption><FilterOption id="799" count="392" label="Ovary tumor"></FilterOption><FilterOption id="1828" count="345" label="Multiple myeloma"></FilterOption><FilterOption id="2454" count="324" label="Glioblastoma"></FilterOption><FilterOption id="205" count="322" label="Melanoma"></FilterOption><FilterOption id="249" count="320" label="Pancreas tumor"></FilterOption><FilterOption id="276" count="303" label="Prostate tumor"></FilterOption><FilterOption id="3657" count="302" label="Metastatic breast cancer"></FilterOption><FilterOption id="319" count="268" label="Non-Hodgkin lymphoma"></FilterOption><FilterOption id="989" count="257" label="Colorectal tumor"></FilterOption><FilterOption id="3665" count="247" label="Metastatic non small cell lung cancer"></FilterOption><FilterOption id="1767" count="245" label="Hepatocellular carcinoma"></FilterOption><FilterOption id="2054" count="238" label="Hematological neoplasm"></FilterOption><FilterOption id="623" count="205" label="Head and neck tumor"></FilterOption><FilterOption id="127" count="191" label="Stomach tumor"></FilterOption><FilterOption id="3658" count="189" label="Metastatic colorectal cancer"></FilterOption><FilterOption id="755" count="184" label="Lung tumor"></FilterOption><FilterOption id="203" count="181" label="Lymphoma"></FilterOption><FilterOption id="1734" count="167" label="Chronic lymphocytic leukemia"></FilterOption><FilterOption id="188" count="165" label="Inflammatory disease"></FilterOption><FilterOption id="3246" count="159" label="Hormone refractory prostate cancer"></FilterOption><FilterOption id="316" count="154" label="B-cell lymphoma"></FilterOption><FilterOption id="1108" count="154" label="Glioma"></FilterOption><FilterOption id="3257" count="152" label="Stage IV melanoma"></FilterOption><FilterOption id="1749" count="149" label="Diffuse large B-cell lymphoma"></FilterOption><FilterOption id="1272" count="144" label="Myelodysplastic syndrome"></FilterOption><FilterOption id="2380" count="143" label="Bladder cancer"></FilterOption><FilterOption id="307" count="125" label="Squamous cell carcinoma"></FilterOption><FilterOption id="427" count="122" label="Uterine cervix tumor"></FilterOption><FilterOption id="36" count="121" label="Autoimmune disease"></FilterOption><FilterOption id="1766" count="120" label="Renal cell carcinoma"></FilterOption><FilterOption id="1728" count="119" label="Acute lymphoblastic leukemia"></FilterOption><FilterOption id="291" count="114" label="Rheumatoid arthritis"></FilterOption><FilterOption id="1261" count="111" label="Small-cell lung cancer"></FilterOption><FilterOption id="199" count="104" label="Leukemia"></FilterOption><FilterOption id="1069" count="104" label="Metastasis"></FilterOption><FilterOption id="3669" count="102" label="Metastatic pancreas cancer"></FilterOption><FilterOption id="20" count="102" label="Pain"></FilterOption><FilterOption id="1011" count="95" label="Esophagus tumor"></FilterOption><FilterOption id="1745" count="95" label="Follicle center lymphoma"></FilterOption><FilterOption id="4250" count="94" label="Metastatic renal cell carcinoma"></FilterOption><FilterOption id="767" count="86" label="Colon tumor"></FilterOption><FilterOption id="1735" count="84" label="Chronic myelocytic leukemia"></FilterOption><FilterOption id="1705" count="84" label="Endometrioid carcinoma"></FilterOption><FilterOption id="3666" count="84" label="Metastatic stomach cancer"></FilterOption><FilterOption id="153" count="82" label="Hepatitis C virus infection"></FilterOption><FilterOption id="3083" count="82" label="Peritoneal tumor"></FilterOption><FilterOption id="1240" count="81" label="Mesothelioma"></FilterOption><FilterOption id="396" count="81" label="Papillomavirus infection"></FilterOption><FilterOption id="152" count="80" label="Hepatitis B virus infection"></FilterOption><FilterOption id="1128" count="78" label="Neuroendocrine tumor"></FilterOption><FilterOption id="202" count="75" label="Liver tumor"></FilterOption><FilterOption id="3866" count="75" label="Metastatic ovary cancer"></FilterOption><FilterOption id="2726" count="75" label="Neuroblastoma"></FilterOption><FilterOption id="760" count="69" label="Brain tumor"></FilterOption><FilterOption id="1765" count="69" label="Cholangiocarcinoma"></FilterOption><FilterOption id="746" count="69" label="Infectious disease"></FilterOption><FilterOption id="2243" count="68" label="Fallopian tube cancer"></FilterOption><FilterOption id="3378" count="68" label="Soft tissue sarcoma"></FilterOption><FilterOption id="1729" count="64" label="B-cell acute lymphoblastic leukemia"></FilterOption><FilterOption id="1744" count="64" label="Mantle cell lymphoma"></FilterOption><FilterOption id="1771" count="63" label="Transitional cell carcinoma"></FilterOption><FilterOption id="213" count="57" label="Multiple sclerosis"></FilterOption><FilterOption id="1991" count="57" label="Neutropenia"></FilterOption><FilterOption id="1736" count="56" label="Hairy cell leukemia"></FilterOption><FilterOption id="158" count="56" label="HIV infection"></FilterOption><FilterOption id="161" count="55" label="Hodgkins disease"></FilterOption><FilterOption id="3673" count="55" label="Metastatic head and neck cancer"></FilterOption><FilterOption id="837" count="55" label="Non-insulin dependent diabetes"></FilterOption><FilterOption id="3466" count="54" label="Metastatic bladder cancer"></FilterOption><FilterOption id="194" count="51" label="Sarcoma"></FilterOption><FilterOption id="131" count="49" label="Gastrointestinal tumor"></FilterOption><FilterOption id="3667" count="47" label="Metastatic esophageal cancer"></FilterOption><FilterOption id="999" count="47" label="Renal tumor"></FilterOption><FilterOption id="1516" count="46" label="Biliary cancer"></FilterOption><FilterOption id="1507" count="46" label="Pancreatic ductal adenocarcinoma"></FilterOption><FilterOption id="14" count="45" label="Alzheimers disease"></FilterOption><FilterOption id="3211" count="45" label="Cancer pain"></FilterOption><FilterOption id="281" count="45" label="Psoriasis"></FilterOption><FilterOption id="1772" count="44" label="Osteosarcoma"></FilterOption><FilterOption id="1127" count="43" label="Fibrosis"></FilterOption><FilterOption id="344" count="43" label="Viral infection"></FilterOption><FilterOption id="1768" count="42" label="Nasopharyngeal carcinoma"></FilterOption><FilterOption id="1134" count="42" label="Thyroid tumor"></FilterOption><FilterOption id="2975" count="41" label="Ewing sarcoma"></FilterOption><FilterOption id="3664" count="41" label="Metastatic prostate cancer"></FilterOption><FilterOption id="1753" count="41" label="Peripheral T-cell lymphoma"></FilterOption><FilterOption id="1754" count="39" label="Cutaneous T-cell lymphoma"></FilterOption><FilterOption id="616" count="39" label="Graft versus host disease"></FilterOption><FilterOption id="936" count="39" label="Kaposis sarcoma"></FilterOption><FilterOption id="233" count="39" label="Neurodegenerative disease"></FilterOption><FilterOption id="246" count="39" label="Osteoporosis"></FilterOption><FilterOption id="185" count="38" label="Immune disorder"></FilterOption><FilterOption id="2436" count="37" label="Myelofibrosis"></FilterOption><FilterOption id="1829" count="36" label="Bone metastases"></FilterOption></Filter><Filter label="Secondary Indications" name="indicationsSecondary" total="100"><FilterOption id="651" count="8846" label="Cancer"></FilterOption><FilterOption id="725" count="1140" label="Solid tumor"></FilterOption><FilterOption id="49" count="859" label="Breast tumor"></FilterOption><FilterOption id="276" count="659" label="Prostate tumor"></FilterOption><FilterOption id="188" count="542" label="Inflammatory disease"></FilterOption><FilterOption id="205" count="484" label="Melanoma"></FilterOption><FilterOption id="799" count="397" label="Ovary tumor"></FilterOption><FilterOption id="989" count="359" label="Colorectal tumor"></FilterOption><FilterOption id="249" count="340" label="Pancreas tumor"></FilterOption><FilterOption id="1262" count="335" label="Non-small-cell lung cancer"></FilterOption><FilterOption id="755" count="313" label="Lung tumor"></FilterOption><FilterOption id="1828" count="261" label="Multiple myeloma"></FilterOption><FilterOption id="291" count="255" label="Rheumatoid arthritis"></FilterOption><FilterOption id="199" count="253" label="Leukemia"></FilterOption><FilterOption id="36" count="248" label="Autoimmune disease"></FilterOption><FilterOption id="1731" count="217" label="Acute myelogenous leukemia"></FilterOption><FilterOption id="158" count="203" label="HIV infection"></FilterOption><FilterOption id="767" count="200" label="Colon tumor"></FilterOption><FilterOption id="54" count="199" label="Carcinoma"></FilterOption><FilterOption id="2054" count="198" label="Hematological neoplasm"></FilterOption><FilterOption id="319" count="193" label="Non-Hodgkin lymphoma"></FilterOption><FilterOption id="1069" count="190" label="Metastasis"></FilterOption><FilterOption id="281" count="181" label="Psoriasis"></FilterOption><FilterOption id="230" count="174" label="Neoplasm"></FilterOption><FilterOption id="623" count="164" label="Head and neck tumor"></FilterOption><FilterOption id="760" count="159" label="Brain tumor"></FilterOption><FilterOption id="185" count="157" label="Immune disorder"></FilterOption><FilterOption id="20" count="157" label="Pain"></FilterOption><FilterOption id="1108" count="154" label="Glioma"></FilterOption><FilterOption id="203" count="150" label="Lymphoma"></FilterOption><FilterOption id="2454" count="140" label="Glioblastoma"></FilterOption><FilterOption id="1767" count="140" label="Hepatocellular carcinoma"></FilterOption><FilterOption id="202" count="135" label="Liver tumor"></FilterOption><FilterOption id="1734" count="131" label="Chronic lymphocytic leukemia"></FilterOption><FilterOption id="1261" count="130" label="Small-cell lung cancer"></FilterOption><FilterOption id="127" count="127" label="Stomach tumor"></FilterOption><FilterOption id="3246" count="122" label="Hormone refractory prostate cancer"></FilterOption><FilterOption id="427" count="119" label="Uterine cervix tumor"></FilterOption><FilterOption id="344" count="117" label="Viral infection"></FilterOption><FilterOption id="57" count="113" label="Cardiovascular disease"></FilterOption><FilterOption id="316" count="112" label="B-cell lymphoma"></FilterOption><FilterOption id="746" count="108" label="Infectious disease"></FilterOption><FilterOption id="3713" count="106" label="Advanced solid tumor"></FilterOption><FilterOption id="213" count="106" label="Multiple sclerosis"></FilterOption><FilterOption id="31" count="102" label="Asthma"></FilterOption><FilterOption id="1766" count="101" label="Renal cell carcinoma"></FilterOption><FilterOption id="1272" count="95" label="Myelodysplastic syndrome"></FilterOption><FilterOption id="14" count="94" label="Alzheimers disease"></FilterOption><FilterOption id="246" count="92" label="Osteoporosis"></FilterOption><FilterOption id="40" count="89" label="Bacterial infection"></FilterOption><FilterOption id="97" count="89" label="Diabetes mellitus"></FilterOption><FilterOption id="153" count="83" label="Hepatitis C virus infection"></FilterOption><FilterOption id="4250" count="83" label="Metastatic renal cell carcinoma"></FilterOption><FilterOption id="233" count="80" label="Neurodegenerative disease"></FilterOption><FilterOption id="1226" count="78" label="Age related macular degeneration"></FilterOption><FilterOption id="396" count="78" label="Papillomavirus infection"></FilterOption><FilterOption id="999" count="77" label="Renal tumor"></FilterOption><FilterOption id="194" count="77" label="Sarcoma"></FilterOption><FilterOption id="515" count="75" label="Transplant rejection"></FilterOption><FilterOption id="3257" count="73" label="Stage IV melanoma"></FilterOption><FilterOption id="422" count="72" label="Angiogenesis disorder"></FilterOption><FilterOption id="42" count="70" label="Bladder tumor"></FilterOption><FilterOption id="677" count="68" label="Neurological disease"></FilterOption><FilterOption id="2380" count="65" label="Bladder cancer"></FilterOption><FilterOption id="1735" count="64" label="Chronic myelocytic leukemia"></FilterOption><FilterOption id="65" count="63" label="Stroke"></FilterOption><FilterOption id="347" count="63" label="Wound healing"></FilterOption><FilterOption id="28" count="62" label="Arthritis"></FilterOption><FilterOption id="330" count="62" label="Restenosis"></FilterOption><FilterOption id="33" count="61" label="Atherosclerosis"></FilterOption><FilterOption id="616" count="61" label="Graft versus host disease"></FilterOption><FilterOption id="3657" count="61" label="Metastatic breast cancer"></FilterOption><FilterOption id="425" count="60" label="Cachexia"></FilterOption><FilterOption id="837" count="60" label="Non-insulin dependent diabetes"></FilterOption><FilterOption id="124" count="59" label="Fungal infection"></FilterOption><FilterOption id="239" count="59" label="Ocular disease"></FilterOption><FilterOption id="189" count="57" label="Inflammatory bowel disease"></FilterOption><FilterOption id="131" count="55" label="Gastrointestinal tumor"></FilterOption><FilterOption id="238" count="55" label="Obesity"></FilterOption><FilterOption id="1728" count="53" label="Acute lymphoblastic leukemia"></FilterOption><FilterOption id="3211" count="53" label="Cancer pain"></FilterOption><FilterOption id="152" count="53" label="Hepatitis B virus infection"></FilterOption><FilterOption id="3665" count="53" label="Metastatic non small cell lung cancer"></FilterOption><FilterOption id="1240" count="52" label="Mesothelioma"></FilterOption><FilterOption id="84" count="48" label="Crohns disease"></FilterOption><FilterOption id="1749" count="48" label="Diffuse large B-cell lymphoma"></FilterOption><FilterOption id="1011" count="48" label="Esophagus tumor"></FilterOption><FilterOption id="576" count="47" label="Diabetic retinopathy"></FilterOption><FilterOption id="1127" count="47" label="Fibrosis"></FilterOption><FilterOption id="161" count="47" label="Hodgkins disease"></FilterOption><FilterOption id="95" count="46" label="Dermatological disease"></FilterOption><FilterOption id="113" count="44" label="Endometriosis"></FilterOption><FilterOption id="936" count="44" label="Kaposis sarcoma"></FilterOption><FilterOption id="1005" count="44" label="Unidentified indication"></FilterOption><FilterOption id="655" count="42" label="Metabolic disorder"></FilterOption><FilterOption id="3658" count="42" label="Metastatic colorectal cancer"></FilterOption><FilterOption id="12" count="40" label="Allergy"></FilterOption><FilterOption id="1829" count="40" label="Bone metastases"></FilterOption><FilterOption id="17" count="39" label="Anemia"></FilterOption><FilterOption id="55" count="39" label="Cardiac failure"></FilterOption></Filter><Filter label="Regulatory Designations" name="drugRegulatoryDesignations" total="19"><FilterOption id="1" count="1464" label="Orphan Drug"></FilterOption><FilterOption id="2" count="433" label="Fast Track"></FilterOption><FilterOption id="3" count="143" label="Breakthrough Therapy"></FilterOption><FilterOption id="11" count="141" label="Priority Review"></FilterOption><FilterOption id="9" count="107" label="Paediatric Investigation Plan"></FilterOption><FilterOption id="5" count="96" label="Accelerated Approval"></FilterOption><FilterOption id="13" count="29" label="Rare Pediatric Disease"></FilterOption><FilterOption id="16" count="23" label="Promising Innovative Medicine"></FilterOption><FilterOption id="10" count="18" label="PRIME"></FilterOption><FilterOption id="18" count="15" label="National Science and Technology Major Project"></FilterOption><FilterOption id="14" count="15" label="Sakigake"></FilterOption><FilterOption id="4" count="13" label="Advanced Therapy Medicinal Product"></FilterOption><FilterOption id="19" count="10" label="Special Review Project"></FilterOption><FilterOption id="17" count="6" label="Regenerative Medicine Advanced Therapy"></FilterOption><FilterOption id="6" count="5" label="Animal Rule"></FilterOption><FilterOption id="7" count="5" label="Emergency Use Authorization"></FilterOption><FilterOption id="12" count="5" label="Qualified Infectious Disease Product"></FilterOption><FilterOption id="8" count="3" label="New Active Substance"></FilterOption><FilterOption id="15" count="1" label="Tropical Disease Priority Review"></FilterOption></Filter><Filter label="Primary Actions" name="actionsPrimary" total="100"><FilterOption id="3756" count="290" label="Erbb2 tyrosine kinase receptor inhibitor"></FilterOption><FilterOption id="740" count="281" label="Epidermal growth factor receptor antagonist"></FilterOption><FilterOption id="142" count="251" label="Topoisomerase II inhibitor"></FilterOption><FilterOption id="141" count="219" label="Topoisomerase I inhibitor"></FilterOption><FilterOption id="5023" count="207" label="CD3 modulator"></FilterOption><FilterOption id="3848" count="182" label="VEGF-2 receptor antagonist"></FilterOption><FilterOption id="5080" count="180" label="B-lymphocyte antigen CD19 modulator"></FilterOption><FilterOption id="1722" count="178" label="VEGF receptor antagonist"></FilterOption><FilterOption id="2574" count="164" label="Histone deacetylase inhibitor"></FilterOption><FilterOption id="3755" count="157" label="Erbb2 tyrosine kinase receptor modulator"></FilterOption><FilterOption id="67136" count="153" label="Programmed cell death protein 1 inhibitor"></FilterOption><FilterOption id="14007" count="151" label="Programmed cell death ligand 1 inhibitor"></FilterOption><FilterOption id="675" count="141" label="Hepatocyte growth factor receptor antagonist"></FilterOption><FilterOption id="1575" count="135" label="Phosphoinositide 3-kinase inhibitor"></FilterOption><FilterOption id="541" count="132" label="Tubulin receptor antagonist"></FilterOption><FilterOption id="3806" count="127" label="Flt3 tyrosine kinase inhibitor"></FilterOption><FilterOption id="5085" count="122" label="B-lymphocyte antigen CD20 inhibitor"></FilterOption><FilterOption id="138" count="114" label="DNA polymerase inhibitor"></FilterOption><FilterOption id="3754" count="113" label="EGFR family tyrosine kinase receptor inhibitor"></FilterOption><FilterOption id="10240" count="109" label="mTOR inhibitor"></FilterOption><FilterOption id="60" count="108" label="Androgen receptor antagonist"></FilterOption><FilterOption id="3605" count="106" label="Epidermal growth factor receptor modulator"></FilterOption><FilterOption id="8012" count="105" label="Hsp 90 inhibitor"></FilterOption><FilterOption id="499" count="103" label="Tubulin binding agent"></FilterOption><FilterOption id="10451" count="98" label="Ras GTPase inhibitor"></FilterOption><FilterOption id="12521" count="98" label="VEGF ligand inhibitor"></FilterOption><FilterOption id="3808" count="91" label="Kit tyrosine kinase inhibitor"></FilterOption><FilterOption id="385" count="90" label="Protein tyrosine kinase inhibitor"></FilterOption><FilterOption id="286" count="87" label="Estrogen receptor antagonist"></FilterOption><FilterOption id="5482" count="84" label="Cytotoxic T-lymphocyte protein-4 inhibitor"></FilterOption><FilterOption id="3859" count="80" label="AKT protein kinase inhibitor"></FilterOption><FilterOption id="431" count="77" label="DNA gyrase inhibitor"></FilterOption><FilterOption id="214" count="76" label="Interferon alpha 2 ligand"></FilterOption><FilterOption id="253" count="75" label="Matrix metalloprotease inhibitor"></FilterOption><FilterOption id="372" count="74" label="Thymidylate synthase inhibitor"></FilterOption><FilterOption id="3576" count="73" label="Src tyrosine kinase inhibitor"></FilterOption><FilterOption id="2653" count="72" label="Nuclear factor kappa B inhibitor"></FilterOption><FilterOption id="12481" count="70" label="Interleukin-2 ligand"></FilterOption><FilterOption id="1875" count="70" label="Protein farnesyltransferase inhibitor"></FilterOption><FilterOption id="7967" count="70" label="STAT-3 inhibitor"></FilterOption><FilterOption id="3758" count="69" label="Erbb3 tyrosine kinase receptor inhibitor"></FilterOption><FilterOption id="948" count="68" label="PDGF receptor antagonist"></FilterOption><FilterOption id="3151" count="67" label="GCSF receptor agonist"></FilterOption><FilterOption id="4917" count="66" label="Proteasome inhibitor"></FilterOption><FilterOption id="3252" count="65" label="Insulin-like growth factor 1 receptor antagonist"></FilterOption><FilterOption id="8255" count="61" label="APRIL receptor modulator"></FilterOption><FilterOption id="3592" count="60" label="Btk tyrosine kinase inhibitor"></FilterOption><FilterOption id="4548" count="60" label="Raf B protein kinase inhibitor"></FilterOption><FilterOption id="3524" count="59" label="Abl tyrosine kinase inhibitor"></FilterOption><FilterOption id="32076" count="59" label="Mucin 1 modulator"></FilterOption><FilterOption id="5083" count="58" label="B-lymphocyte antigen CD20 modulator"></FilterOption><FilterOption id="9267" count="57" label="Glutamate carboxypeptidase II modulator"></FilterOption><FilterOption id="5141" count="56" label="CD40 ligand receptor agonist"></FilterOption><FilterOption id="293" count="56" label="Opioid receptor mu agonist"></FilterOption><FilterOption id="5450" count="55" label="CDw137 agonist"></FilterOption><FilterOption id="3154" count="55" label="CSF-1 antagonist"></FilterOption><FilterOption id="4314" count="55" label="Cyclin-dependent kinase-4 inhibitor"></FilterOption><FilterOption id="3850" count="55" label="VEGF-3 receptor antagonist"></FilterOption><FilterOption id="50096" count="54" label="Cancer testis antigen NY-ESO-1 modulator"></FilterOption><FilterOption id="3846" count="54" label="VEGF-1 receptor antagonist"></FilterOption><FilterOption id="135" count="52" label="DHFR inhibitor"></FilterOption><FilterOption id="19115" count="52" label="HLA class I antigen A-2 alpha modulator"></FilterOption><FilterOption id="1001" count="51" label="Cyclooxygenase 2 inhibitor"></FilterOption><FilterOption id="5185" count="50" label="CD47 antagonist"></FilterOption><FilterOption id="3564" count="50" label="Jak2 tyrosine kinase inhibitor"></FilterOption><FilterOption id="3736" count="49" label="Anaplastic lymphoma kinase receptor inhibitor"></FilterOption><FilterOption id="11183" count="49" label="Phosphoinositide-3 kinase delta inhibitor"></FilterOption><FilterOption id="13571" count="48" label="Bcr protein inhibitor"></FilterOption><FilterOption id="34558" count="47" label="Bromodomain containing protein inhibitor"></FilterOption><FilterOption id="4310" count="46" label="Cyclin-dependent kinase-2 inhibitor"></FilterOption><FilterOption id="846" count="46" label="Estrogen receptor modulator"></FilterOption><FilterOption id="168" count="46" label="FGF receptor antagonist"></FilterOption><FilterOption id="2458" count="46" label="Integrin alpha-V/beta-3 antagonist"></FilterOption><FilterOption id="2507" count="46" label="PARP inhibitor"></FilterOption><FilterOption id="334" count="46" label="Protein kinase C inhibitor"></FilterOption><FilterOption id="814" count="46" label="Tubulin modulator"></FilterOption><FilterOption id="52970" count="45" label="GCSF ligand"></FilterOption><FilterOption id="1120" count="45" label="Somatostatin receptor agonist"></FilterOption><FilterOption id="76" count="44" label="Aromatase inhibitor"></FilterOption><FilterOption id="11484" count="44" label="Mesothelin modulator"></FilterOption><FilterOption id="5443" count="44" label="OX-40 receptor agonist"></FilterOption><FilterOption id="221" count="43" label="IL-2 receptor agonist"></FilterOption><FilterOption id="3742" count="42" label="Axl tyrosine kinase receptor inhibitor"></FilterOption><FilterOption id="16111" count="42" label="Bcl-2 protein inhibitor"></FilterOption><FilterOption id="3137" count="42" label="CXCR4 chemokine antagonist"></FilterOption><FilterOption id="455" count="42" label="GNRH receptor antagonist"></FilterOption><FilterOption id="1092" count="41" label="GNRH receptor agonist"></FilterOption><FilterOption id="3085" count="41" label="IL-15 receptor agonist"></FilterOption><FilterOption id="1614" count="41" label="Telomerase inhibitor"></FilterOption><FilterOption id="5281" count="40" label="CD66e modulator"></FilterOption><FilterOption id="3682" count="40" label="FGF1 receptor antagonist"></FilterOption><FilterOption id="4762" count="40" label="MEK-1 protein kinase inhibitor"></FilterOption><FilterOption id="34570" count="39" label="Bromodomain containing protein 4 inhibitor"></FilterOption><FilterOption id="2596" count="39" label="Cyclin dependent kinase inhibitor"></FilterOption><FilterOption id="7827" count="39" label="TLR-9 agonist"></FilterOption><FilterOption id="8110" count="38" label="Cyclin-dependent kinase-9 inhibitor"></FilterOption><FilterOption id="19106" count="38" label="HLA antigen modulator"></FilterOption><FilterOption id="4420" count="37" label="Aurora protein kinase 2 inhibitor"></FilterOption><FilterOption id="15709" count="37" label="Beta-catenin inhibitor"></FilterOption><FilterOption id="5119" count="37" label="CD33 modulator"></FilterOption></Filter><Filter label="Primary Companies" name="companiesPrimary" total="100"><FilterOption id="20519" count="123" label="National Cancer Institute"></FilterOption><FilterOption id="23137" count="112" label="Novartis AG"></FilterOption><FilterOption id="18767" count="102" label="Pfizer Inc"></FilterOption><FilterOption id="14190" count="74" label="AstraZeneca plc"></FilterOption><FilterOption id="1072507" count="72" label="AbbVie Inc"></FilterOption><FilterOption id="18077" count="72" label="Merck &amp; Co Inc"></FilterOption><FilterOption id="15065" count="69" label="Bristol-Myers Squibb Co"></FilterOption><FilterOption id="23382" count="62" label="MD Anderson Cancer Center"></FilterOption><FilterOption id="19446" count="61" label="Roche Holding AG"></FilterOption><FilterOption id="19453" count="58" label="Genentech Inc"></FilterOption><FilterOption id="20518" count="58" label="National Institutes of Health"></FilterOption><FilterOption id="28355" count="56" label="GlaxoSmithKline plc"></FilterOption><FilterOption id="1009547" count="55" label="Sanofi SA"></FilterOption><FilterOption id="15331" count="54" label="Celgene Corp"></FilterOption><FilterOption id="17810" count="53" label="Eli Lilly &amp; Co"></FilterOption><FilterOption id="14109" count="52" label="Amgen Inc"></FilterOption><FilterOption id="20300" count="52" label="Takeda Pharmaceutical Co Ltd"></FilterOption><FilterOption id="22122" count="45" label="Memorial Sloan-Kettering Cancer Center"></FilterOption><FilterOption id="14455" count="41" label="Bayer AG"></FilterOption><FilterOption id="15414" count="40" label="Chugai Pharmaceutical Co Ltd"></FilterOption><FilterOption id="20596" count="40" label="Johns Hopkins University"></FilterOption><FilterOption id="1017506" count="39" label="Daiichi Sankyo Co Ltd"></FilterOption><FilterOption id="15872" count="39" label="Eisai Co Ltd"></FilterOption><FilterOption id="18681" count="38" label="Ono Pharmaceutical Co Ltd"></FilterOption><FilterOption id="18008" count="35" label="MedImmune LLC"></FilterOption><FilterOption id="20534" count="34" label="Baylor College of Medicine"></FilterOption><FilterOption id="14881" count="34" label="Boehringer Ingelheim International GmbH"></FilterOption><FilterOption id="19863" count="32" label="Servier"></FilterOption><FilterOption id="25314" count="32" label="Shanghai Institute of Materia Medica of the Chinese Academy of Sciences"></FilterOption><FilterOption id="1013295" count="31" label="Astellas Pharma Inc"></FilterOption><FilterOption id="21231" count="31" label="China Pharmaceutical University"></FilterOption><FilterOption id="1003379" count="30" label="Sichuan University"></FilterOption><FilterOption id="20623" count="30" label="University of Michigan"></FilterOption><FilterOption id="1083716" count="29" label="Johns Hopkins Technology Ventures"></FilterOption><FilterOption id="16218" count="28" label="Fred Hutchinson Cancer Research Center"></FilterOption><FilterOption id="26997" count="28" label="Janssen Biotech Inc"></FilterOption><FilterOption id="29469" count="27" label="Cancer Research UK"></FilterOption><FilterOption id="15615" count="27" label="Dana-Farber Cancer Institute Inc"></FilterOption><FilterOption id="1015036" count="27" label="NantKwest Inc"></FilterOption><FilterOption id="17216" count="26" label="Incyte Corp"></FilterOption><FilterOption id="1048574" count="26" label="Sorrento Therapeutics Inc"></FilterOption><FilterOption id="18720" count="26" label="Taiho Pharmaceutical Co Ltd"></FilterOption><FilterOption id="1025425" count="25" label="Chia Tai Tianqing Pharmaceutical Group Co Ltd"></FilterOption><FilterOption id="19898" count="25" label="Shionogi &amp; Co Ltd"></FilterOption><FilterOption id="1006925" count="24" label="Jiangsu Hengrui Medicine Co Ltd"></FilterOption><FilterOption id="17332" count="24" label="Johnson &amp; Johnson"></FilterOption><FilterOption id="29060" count="24" label="MacroGenics Inc"></FilterOption><FilterOption id="18101" count="24" label="Merck KGaA"></FilterOption><FilterOption id="20573" count="23" label="Emory University"></FilterOption><FilterOption id="19214" count="23" label="Regeneron Pharmaceuticals Inc"></FilterOption><FilterOption id="25554" count="23" label="Seattle Genetics Inc"></FilterOption><FilterOption id="30044" count="22" label="Aurigene Discovery Technologies Ltd"></FilterOption><FilterOption id="1070750" count="22" label="Innovent Biologics Inc"></FilterOption><FilterOption id="17259" count="22" label="Ipsen"></FilterOption><FilterOption id="1042596" count="22" label="Kyowa Hakko Kirin Co Ltd"></FilterOption><FilterOption id="1073079" count="22" label="Shanghai Henlius Biotech Co Ltd"></FilterOption><FilterOption id="20567" count="21" label="Duke University"></FilterOption><FilterOption id="21102" count="21" label="Scripps Research Institute"></FilterOption><FilterOption id="25623" count="21" label="University of California Los Angeles"></FilterOption><FilterOption id="20626" count="21" label="University of Minnesota"></FilterOption><FilterOption id="15742" count="20" label="Dong-A ST Co Ltd"></FilterOption><FilterOption id="16450" count="20" label="Gilead Sciences Inc"></FilterOption><FilterOption id="1056870" count="20" label="Kite Pharma Inc"></FilterOption><FilterOption id="1104834" count="20" label="NantCell Inc"></FilterOption><FilterOption id="20348" count="20" label="Teva Pharmaceutical Industries Ltd"></FilterOption><FilterOption id="1016672" count="19" label="3SBio Inc"></FilterOption><FilterOption id="1135041" count="19" label="ABL Bio Inc"></FilterOption><FilterOption id="26879" count="19" label="Novartis Institutes for BioMedical Research Inc"></FilterOption><FilterOption id="1004998" count="19" label="Shenyang Pharmaceutical University"></FilterOption><FilterOption id="29954" count="19" label="TTY Biopharm Co Ltd"></FilterOption><FilterOption id="23221" count="18" label="Agenus Inc"></FilterOption><FilterOption id="17202" count="18" label="ImmunoGen Inc"></FilterOption><FilterOption id="17204" count="18" label="Immunomedics Inc"></FilterOption><FilterOption id="22403" count="18" label="Inovio Pharmaceuticals Inc"></FilterOption><FilterOption id="19862" count="18" label="Merck Serono SA"></FilterOption><FilterOption id="1007316" count="18" label="Perseus Proteomics Inc"></FilterOption><FilterOption id="20663" count="18" label="Purdue University"></FilterOption><FilterOption id="20659" count="18" label="University of Pittsburgh"></FilterOption><FilterOption id="1014227" count="18" label="WuXi PharmaTech (Cayman) Inc"></FilterOption><FilterOption id="1161108" count="17" label="Biosion Inc"></FilterOption><FilterOption id="23863" count="17" label="Chinese Academy of Sciences"></FilterOption><FilterOption id="1070979" count="17" label="GigaGen Inc"></FilterOption><FilterOption id="29603" count="17" label="H Lee Moffitt Cancer Center and Research Institute"></FilterOption><FilterOption id="1006185" count="17" label="Xiamen University"></FilterOption><FilterOption id="1088700" count="16" label="Allergan plc"></FilterOption><FilterOption id="30620" count="16" label="Cancer Research Technology Ltd"></FilterOption><FilterOption id="27692" count="16" label="Cellectar Biosciences Inc"></FilterOption><FilterOption id="19087" count="16" label="Pierre Fabre SA"></FilterOption><FilterOption id="1085850" count="16" label="Suzhou Alphamab Co Ltd"></FilterOption><FilterOption id="16587" count="15" label="Grunenthal GmbH"></FilterOption><FilterOption id="16611" count="15" label="Hanmi Pharmaceutical Co Ltd"></FilterOption><FilterOption id="1129349" count="15" label="KSQ Therapeutics"></FilterOption><FilterOption id="20645" count="15" label="Northwestern University"></FilterOption><FilterOption id="20575" count="15" label="University of Florida"></FilterOption><FilterOption id="1051889" count="14" label="Betta Pharmaceuticals Co Ltd"></FilterOption><FilterOption id="1053219" count="14" label="Eureka Therapeutics Inc"></FilterOption><FilterOption id="30752" count="14" label="Onconova Therapeutics Inc"></FilterOption><FilterOption id="1062326" count="14" label="Selvita SA"></FilterOption><FilterOption id="20679" count="14" label="Stanford University"></FilterOption><FilterOption id="1082084" count="14" label="University of California Technology Transfer Office"></FilterOption></Filter><Filter label="Highest Phase" name="phaseHighest" total="13"><FilterOption id="NDR" count="10920" label="No Development Reported"></FilterOption><FilterOption id="DR" count="6832" label="Discovery"></FilterOption><FilterOption id="DX" count="2243" label="Discontinued"></FilterOption><FilterOption id="C2" count="1328" label="Phase 2 Clinical"></FilterOption><FilterOption id="C1" count="1273" label="Phase 1 Clinical"></FilterOption><FilterOption id="L" count="1050" label="Launched"></FilterOption><FilterOption id="C3" count="344" label="Phase 3 Clinical"></FilterOption><FilterOption id="CU" count="105" label="Clinical"></FilterOption><FilterOption id="PR" count="61" label="Pre-registration"></FilterOption><FilterOption id="S" count="39" label="Suspended"></FilterOption><FilterOption id="R" count="37" label="Registered"></FilterOption><FilterOption id="W" count="22" label="Withdrawn"></FilterOption><FilterOption id="OL" count="5" label="Outlicensed"></FilterOption></Filter></Filters></ns2:com.thomsonreuters.ls.service.contract.soap.drugs.v2.DrugResultsOutput>